• Denali Therapeutics (NASDAQ:DNLI) Hits New 52-Week Low on Analyst Downgrade

    Source: Buzz FX / 05 Mar 2025 11:26:13   America/New_York


    Denali Therapeutics (NASDAQ:DNLI) Hits New 52-Week Low on Analyst Downgrade Written by MarketBeat March 5, 2025 Share Link copied to clipboard. Denali Therapeutics Inc. ( NASDAQ:DNLI - Get Free Report ) hit a new 52-week low on Tuesday afte
    Read more...
Share on,